Clinical Trials Logo

Clinical Trial Summary

The main goal of this study the possible involvement of netrin-1 into the pathophysiology of placenta accrete spectrum. To delineate the role of netrin-1, neogenin - zeb1 signaling pathway in mechanism of morbidly adherent placenta.


Clinical Trial Description

The main goal of this study is: - To shed light on the possible involvement of netrin-1 into the pathophysiology of placenta accrete spectrum. - To study the role of netrin-1 in Epithelial to mesenchymal transition as a possible pathophysiological mechanism of placenta accrete spectrum. - To delineate the role of netrin-1, neogenin - zeb1 signaling pathway in the progression of invasion of placenta accrete spectrum. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04628169
Study type Observational
Source Assiut University
Contact
Status Completed
Phase
Start date December 1, 2021
Completion date December 1, 2023